Skip to main content

Table 2 Univariate and multivariate analysis of OS

From: Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study

Factors

Univariate analysis

Multivariate Analysis

HR (95% CI)

P value

HR (95% CI)

P value

Gender

0.393 (0.283–0.546)

< 0.001

0.538 (0.352–0.821)

0.004

Age (year)

1.049 (1.033–1.066)

< 0.001

1.042 (1.025–1.058)

< 0.001

Tumor size (cm)

1.461 (1.288–1.657)

< 0.001

1.274 (1.075–1.510)

0.005

Smoking history

2.067 (1.558–2.742)

< 0.001

1.107 (0.764–1.603)

0.592

8th TNM stage

1.818 (1.364–2.425)

< 0.001

1.196 (0.762–1.878)

0.437

Visceral pleural invasion

1.281 (0.973–1.687)

0.077

1.180 (0.818–1.702)

0.377

Histology

 Squamous cell carcinoma

Ref

 

Ref

 

 Adenocarcinoma

0.629 (0.459–0.864)

0.004

1.061 (0.745–1.513)

0.742

 Others

0,946 (0.581–1.1542)

0.825

1.225 (0.734–2.043)

0.437

Differentiation degree

1.683 (1.341–2.112)

< 0.001

1.349 (1.063–1.711)

0.014

Vascular invasion

1.899 (1.119–3.222)

0.017

1.398 (0.805–2.429)

0.235

Number of N2 LNs examined

 0–2

Ref

   

 3–5

0.427 (0.244–0.783)

0.006

0.565 (0.302–1.056)

0.073

 6–8

0.629 (0.368–1.073)

0.089

0.745 (0.429–1.294)

0.296

 9–11

0.516 (0.292–0.913)

0.023

0.663 (0.367–1.198)

0.174

 12–14

0.648 (0.372–1.129)

0.126

0.887 (0.497–1.583)

0.686

 > 14

0.563 (0.342–0.929)

0.024

0.654 (0.388–1.102)

0.111

Adjuvant chemotherapy

0.925 (0.625–1.369)

0.695

  

Thoracotomy or VATS

0.864 (0.655–1.141)

0.304

  

Number of N1 LNs examined

 0–2

Ref

 

Ref

 

 3–5

0.702 (0.451–1.091)

0.116

0.631 (0.403–0.987)

0.044

 6–8

0.533 (0.336–0.844)

0.007

0.489 (0.307–0.779)

0.003

 9–11

0.630 (0.398–0.997)

0.049

0.599 (0.375–0.957)

0.032

 > 11

0.527 (0.329–1.845)

0.008

0.434 (0.269–0.701)

0.001